Clinical trials on CIK cells: First report of the international registry on CIK cells (IRCC)

Journal of Cancer Research and Clinical Oncology

Volumn 137, Issue 2, 2011, Pages 305-310

  Hontscha, C ^a   Borck, Y ^a   Zhou, H ^a   Messmer, D ^b   Schmidt Wolf, I G H ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

CIK cells; Clinical trials; Immunotherapy; International registry

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA FETOPROTEIN; CA 19-9 ANTIGEN; CA 72-4 ANTIGEN; CARCINOEMBRYONIC ANTIGEN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANEMIA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER REGISTRY; CELL THERAPY; CHILL; CLINICAL TRIAL (TOPIC); CYTOKINE INDUCED KILLER CELL; FEMALE; FEVER; FLOW CYTOMETRY; HEADACHE; HEMATOLOGIC DISEASE; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; HYPOTENSION; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDLINE; NATURAL KILLER T CELL; NAUSEA AND VOMITING; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUALITY OF LIFE; STOMACH CANCER; THROMBOCYTOPENIA; TREATMENT RESPONSE; TUMOR VOLUME;

ADULT; AGED; CLINICAL TRIALS AS TOPIC; CYTOKINE-INDUCED KILLER CELLS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOTHERAPY; INTERNATIONAL COOPERATION; MALE; MIDDLE AGED; NEOPLASMS; PATIENT SELECTION; QUALITY OF LIFE; RECURRENCE; REGISTRIES; TREATMENT OUTCOME;

EID: 78751628167     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-010-0887-7     Document Type: Article

References (6)

1. JK Chan CA Hamilton MK Cheung M Karimi J Baker JG Gall, et al. 2006 Enhanced killing of primary ovarian cancer by retargeting autologous cytokine-induced killer cells with bispecific antibodies: a preclinical study Clin Cancer Res 12 1859 1867 1:CAS:528:DC%2BD28Xis1Cjsb8%3D 10.1158/1078-0432. CCR-05-2019 16551871
2. Kim HM, Lim J, Park S-K, Kang JS, Lee K, Lee CW et al (2007) Antitumour activity of cytokine-induced killer cells against human lung cancer. http://www.sciencedirect.com : International Immunopharmacology
3. PH Lu RS Negrin 1994 A novel population of expanded human CD 3+ CD 56+ cells derived from T cells with potent in vivo antitumour activity in SCID mice J Immunol 153 1687 1696 1:CAS:528:DyaK2cXlslOmu7k%3D 7519209
4. KA Margolin RS Negrin KK Wong S Chatterjee C Wright SJ Forman 1997 Cellular Immunotherapy and autologous transplantation for hematologic malignancy Immunol Rev 157 231 240 1:STN:280:DyaK2szpvFGjtQ%3D%3D 10.1111/j.1600-065X. 1997.tb00986.x 9255634 (Pubitemid 27303133)
5. IGH Schmidt-Wolf S Finke B Trojaneck A Denkena P Lefterova N Schwella H-G Heuft G Prange M Korte M Takeya T Dorbic A Neubauer B Wittig D Huhn 1999 Phase 1 clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma Br J Cancer 81 6 1009 1016 1:CAS:528:DyaK1MXnvFSjsL4%3D 10.1038/sj.bjc.6690800 10576658 (Pubitemid 29516145)
6. M Shi B Zhang Z-R Tang Z-Y Lei H-F Wang Y-Y Feng Z-P Fan D-P Xu FS Wang 2004 Autologous cytokine-induced killer cell therapy in clinical trial phase 1 is safe in patients with primary hepatocellular carcinoma World J Gastroenterol 10 8 1146 1151 1:CAS:528:DC%2BD2cXksFGltrY%3D 15069715